Selective activation of the JNK/AP-1 pathway in Fas-mediated apoptosis of rheumatoid arthritis synoviocytes

Arthritis and Rheumatism

Volumn 40, Issue 5, 1997, Pages 919-926

  Okamoto, Kazuyoshi ^a   Fujisawa, Koushi ^a   Hasunuma, Tomoko ^a   Kobata, Tetsuji ^a   Sumida, Takayuki ^a   Nishioka, Kusuki ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME INHIBITOR; FAS ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE; ORTHOVANADIC ACID; PHOSPHATASE; PROTEIN TYROSINE KINASE INHIBITOR; TRANSCRIPTION FACTOR AP 1;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; ETIOLOGY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN PHOSPHORYLATION; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SYNOVIOCYTE;

EID: 0030949608     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.1780400521     Document Type: Article

References (37)

1. Nakajima T, Aono H, Hasunuma T, Yamamoto K, Shirai T, Hirohata K, Nishioka K: Apoptosis and functional Fas antigen in rheumatoid arthritis synoviocytes. Arthritis Rheum 38:485-491, 1995
2. Firestein GS, Yeo M, Zvaifler NJ: Apoptosis in rheumatoid arthritis synovium. J Clin Invest 96:1631-1638, 1995
3. Dérijard B, Hibi M, Wu I-H, Barrett T, Su B, Deng T, Karin M, Davis RJ: JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-jun activation domain. Cell 76:1025-1038, 1994
4. Kyriakis JM, Banerjee P, Nikolakaki E, Dai T, Rubie EA, Ahmad MF, Avruch J, Woodgett JR: The stress-activated protein kinase subfamily of c-jun kinases. Nature 369:156-160, 1994
5. Davis RJ: MAPKs: new JNK expands the group. Trends Biochem Sci 19:470-473, 1994
6. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME: Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270:1326-1331, 1995
7. Gulbins E, Bissonnette R, Mahboubi A, Martin S, Nishioka W, Brunner T, Baier G, Baier-Bitterlich G, Byrd C, Lang F, Kolesnick R, Altman A, Green D: Fas-induced apoptosis is mediated via a ceramide-initiated Ras signaling pathway. Immunity 2:341-351, 1995
8. Sato T, Irie S, Kitada S, Reed JC: FAP-1: a protein tyrosine phosphatase that associates with Fas, Science 268:411-415, 1995
9. Hasunuma T, Nakajima T, Aono H, Sato K, Matsubara T, Yamamoto K, Nishioka K: Establishment and characterization of synovial cell clones with integrated human T-cell leukemia virus type-1. Clin Immunol Immunopathol 72:90-97, 1994
10. Cobb MH, Robbins DJ, Boulton TG: ERKs, extracellular signal-regulated MAP-2 kinases. Curr Opin Cell Biol 3:1025-1032, 1991
11. Ahn NG, Seger R, Krebs EG: The mitogen-activated protein kinase activator. Curr Opin Cell Biol 4:992-999, 1992
12. Davis RJ: The mitogen-activated protein kinase signal transduction pathway. J Biol Chem 268:14553-14556, 1993
13. Gupta S, Campbell D, Dérijard B, Davis RJ: Transcription factor ATF2 regulation by the JNK signal transduction pathway. Science 267:389-393, 1995
14. Alderson MR, Armitage RJ, Maraskovsky E, Tough TW, Roux E, Schooley K, Ramsdell F, Lynch DH: Fas transduces activation signals in normal human T lymphocytes. J Exp Med 178:2231-2235, 1993
15. Mapara MY, Bargou R, Zugok C, Dohner H, Ustaoglu F, Jonker RR, Krammer PH, Dorken B: Apo-1 mediated apoptosis or proliferation in human chronic B lymphocytic leukemia: correlation with bcl-2 oncogene expression. Eur J Immunol 23:702-708, 1993
16. Cifone MG, de Maria R, Roncaioli P, Rippo MR, Azuma M, Lanier LL, Santoni A, Testi R: Apoptotic signaling through CD95 (Fas/Apo-1) activates an acidic sphingomyelinase. J Exp Med 180:1547-1552, 1994
17. Gill BM, Nishikata H, Chan G, Delovitch TL, Ochi A: Fas antigen and sphingomyelin-ceramide turnover-mediated signaling: role in life and death of T lymphocytes. Immunol Rev 142:113-126, 1994
18. Kolesnick R, Golde DW: The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling. Cell 77:325-328, 1994
19. Robey E, Allison JP: T-cell activation: integration of signals from the antigen receptor and costimulatory molecules. Immunol Today 16:306-310, 1995
20. Verheij M, Bose R, Lin XH, Yao B, Jarvis WD, Grant S, Birrer MJ, Szabo E, Zon LI, Kyriakis JM, Haimovitz-Friedman A, Fuks Z, Kolesnick RN: Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature 380:75-79, 1996
21. Smeyne RJ, Vendrell M, Heyward M, Baker SJ, Miao GG, Schilling K, Robertson LM, Curran T, Morgan JI: Continuous c-fos expression precedes programmed cell death in vivo. Nature 363:166-169, 1993
22. Miura M, Zhu H, Rotello R, Hartweig EA, Yuan J: Induction of apoptosis in fibroblasts by IL-1β-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3. Cell 75:653-660, 1993
23. Kuida K, Lippke JA, Ku G, Harding MW, Livingston DJ, Su MS-S, Flavell RA: Altered cytokine export and apoptosis in mice deficient in interleukin-1β converting enzyme. Science 267:2000-2003, 1995
24. Pronk GJ, Ramer K, Amiri P, Williams LT: Requirement of an ICE-like protease for induction of apoptosis and ceramide generation by REAPER. Science 271:808-810, 1996
25. Li P, Alien H, Banerjee S, Franklin S, Herzog L, Johnston C, McDowell J, Paskind M, Rodman L, Salfeld J, Towne E, Tracey D, Wardwell S, Wei F-Y, Kamen R, Seshadri T: Mice deficient in IL-lβ-converting enzyme are defective in production of mature IL-1β and resistant to endotoxic shock. Cell 80:401-411, 1995
26. Sekine C, Yagita H, Kobata T, Hasunuma T, Nishioka K, Okumura K: Fas-mediated stimulation induces IL-8 secretion by rheumatoid arthritis synoviocytes independently of CPP32-mediated apoptosis. Biophys Biochem Res Commun 228:14-20, 1996
27. Nicholson DW, Ali A, Thornberry NA, Vaillancort JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnik YA, Munday NA, Raju SM, Smulson ME, Yamin T-T, Yu VL, Miller DK: Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376:37-43, 1995
28. Chinnaiyan AM, O'Rourke K, Tweari M, Dixit VM: FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 81:505-512, 1995
29. Stanger BZ, Leder P, Lee T-H, Kim E, Seed B: RIP: a novel protein containing a death domain that interacts with Fas/Apo-1 (CD95) in yeast and causes cell death. Cell 81:513-523, 1995
30. Chu K, Niu X, Williams LT: A Fas-associated protein factor, FAF1, potentiates Fas-mediated apoptosis. Proc Natl Acad Sci USA 92:11894-11898, 1995
31. Chinnaiyan AM, Tepper CG, Seldin MF, O'Rourke K, Kischkel FC, Hellbardt S, Krammer PH, Peter ME, Dixit VM: FADD/MORT1 is a common mediator of CD95 (Fas/Apo-1) and tumor necrosis factor receptor-induced apoptosis. J Biol Chem 271:4961-4965, 1996
32. Itoh N, Yonehara S, Ishii A, Yonehara M, Misushima S, Sameshima M, Hase A, Seto Y, Nagata S: The polypeptide encoded by the cDNA for human cell surface antigen fas can mediate apoptosis. Cell 66:233-243, 1991
33. Eischen CM, Dick CJ, Leibson PJ: Tyrosine kinase activation provides an early and requisite signal for Fas-induced apoptosis. J Immunol 153:1947-1954, 1994
34. Wilson DJ, Fortner KA, Lynch DH, Mattingly RR, Macara IG, Posada JA, Budd RC: JNK, but not MAPK, activation is associated with Fas-mediated apoptosis in human T cells. Eur J Immunol 26:989-994, 1996
35. Latinis KM, Koretzky GA: Fas ligation induces apoptosis and Jun kinase activation independently of CD45 and Lck in human T cells. Blood 87:871-875, 1996
36. Hoa TTM, Hasunuma T, Aono H, Masuko K, Kobata T, Yamamoto K, Sumida T, Nishioka K: Novel mechanisms of selective apoptosis in synovial T cells of patients with rheumatoid arthritis. J Rheumatol 23:1332-1337, 1996
37. Fujisawa K, Asahara H, Okamoto K, Aono H, Hasunuma T, Kobata T, Iwakura Y, Yonehara S, Sumida T, Nishioka K: Therapeutic effect of the anti-Fas antibody on arthritis in HTLV-I tax transgenic mice. J Clin Invest 98:271-278, 1996